[BioC] Inconsistency in RMA results from 'affy' and results from 'oligo'
Peng Yu
pengyu.ut at gmail.com
Tue Aug 11 04:45:27 CEST 2009
On Mon, Aug 10, 2009 at 9:22 PM, Sean Davis<seandavi at gmail.com> wrote:
>
>
> On Mon, Aug 10, 2009 at 9:30 PM, Peng Yu <pengyu.ut at gmail.com> wrote:
>>
>> Hi Benilton,
>>
>> If both of scripts do not generate errors, does it mean that both of
>> them are correct? But the RMA results are very different, so one of
>> them must be wrong?
>
> The probesets for the genest arrays are designed roughly against exons and
> as Benilton pointed out, the current behavior of oligo is to summarize the
> probesets. Given that there are >200k exons in the human genome, one should
> expect >200k rows in the rma-normalized data from oligo. Affy, on the other
> hand, uses the unofficial cdf that you downloaded and summarizes to
> transcripts. So, both are correct, but you are trying to compare apples to
> oranges.
I'm still confused what a probeset does not corresponds a transcript.
Could you give me a formal definition on probeset?
The book Bioinformatics and Computational Biology Solutions Using R
and Bioconductor says "Affymetrix arrays typically use between 11 and
20 probe pairs, referred to as a probeset, for each gene." But I don't
see a clear definition of probeset for all types of arrays listed on
http://bioconductor.org/docs/workflows/oligoarrays/
Another question: since 'affy' can also process Affymetrix Gene ST
Arrays, why only 'oligo' but not 'affy' is listed on the above
workflow page?
Regards,
Peng
More information about the Bioconductor
mailing list